Identification and Validation of Candidate Gene Module Along With Immune Cells Infiltration Patterns in Atherosclerosis Progression to Plaque Rupture via Transcriptome Analysis

Abstract

ObjectiveTo explore the differentially expressed genes (DEGs) along with infiltrating immune cells landscape and their potential mechanisms in the progression of atherosclerosis from onset to plaque rupture.MethodsIn this study, three atherosclerosis-related microarray datasets were downloaded from the NCBI-GEO database. The gene set enrichment analysis (GSEA) was performed for interpreting the biological insights of gene expression data. The CIBERSORTx algorithm was applied to infer the relative proportions of infiltrating immune cells of the atherosclerotic samples. DEGs of the datasets were screened using R. The protein interaction network was constructed via STRING. The cluster genes were analyzed by the Cytoscape software. Gene ontology (GO) enrichment was performed via geneontology.org. The least absolute shrinkage and selection operator (LASSO) logistic regression algorithm and receiver operating characteristics (ROC) analyses were performed to build machine learning models for differentiating atherosclerosis status. The Pearson correlation analysis was carried out to illustrate the relationship between cluster genes and immune cells. The expression levels of the cluster genes were validated in two external cohorts. Transcriptional factors and drug-gene interaction analysis were performed to investigate the promising targets for atherosclerosis intervention.ResultsPathways related to immunoinflammatory responses were identified according to GSEA analysis, and the detailed fractions infiltrating immune cells were compared between the early and advanced atherosclerosis. Additionally, we identified 170 DEGs in atherosclerosis progression (|log2FC|≥1 and adjusted p < 0.05). They were mainly enriched in GO terms relating to inflammatory response and innate immune response. A cluster of nine genes, such as ITGB2, C1QC, LY86, CTSS, C1QA, CSF1R, LAPTM5, VSIG4, and CD163, were found to be significant, and their correlations with infiltrating immune cells were calculated. The cluster genes were also validated to be upregulated in two external cohorts. Moreover, C1QA and ITGB2 may exert pathogenic functions in the entire process of atherogenesis.ConclusionsWe reanalyzed the transcriptomic signature of atherosclerosis development from onset to plaque rupture along with the landscape of the immune cell, as well as revealed new insights and specific prospective DEGs for the investigation of disease-associated dynamic molecular processes and their regulations with immune cells.

A comprehensive analysis of the co-pathogenesis of atrial fibrillation and atherosclerosis based on bioinformatics

“…As an indicator of cardiovascular disease, C1q is associated with coronary artery disease [32]. The level of C1q (C1QC) may be a contributing factor to atherosclerotic plaque rupture or instability [33]. Lupus erythematosus and glomerulonephritis are associated with C1q de ciency [34].…”

“…LAPTM5 negatively regulates Tregs[63], Promotes α-SMA, collagen I, and collagen III expressions leading to atrial brosis and may lead to AF generation. As a result of bioinformatics analysis, LAPTM5 has been identi ed as a potential biomarker for left ventricular hypertrophy and hypertension[64], In patients with arteriosclerosis, upregulation was also evident [33]. LAPTM5 may be a potential biomarker for AF or AS disease occurrence.…”

An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis

“…Currently, the diagnosis of HAP heavily relies on clinical manifestations, functional outcomes, and invasive intravascular imaging techniques such as computed tomography angiography and magnetic resonance angiography that thoroughly assess vessel stenosis and wall thickness. Non-invasive medical imaging can accurately identify vulnerable plaques and stratify cardiovascular risk with the advancement of molecular biology and non-invasive molecular tools developed for the diagnosis and risk stratification of atherosclerotic plaques (6)(7)(8)(9)(10)(11)(12)(13)(14).…”

Identification and validation of immune cells and hub genes alterations in recurrent implantation failure: A GEO data mining study

“…In recent years, with the development and widespread use of high throughput “omics” approaches, bioinformatics analysis can be applied to mine these published data to identify novel genes and biomarkers for many diseases ( Segundo-Val and Sanz-Lozano, 2016 ; Xu et al, 2022 ). For instance, Lin et al used bioinformatics analysis to identify AXL, SLC7A11, and ubiquilin 1 (UBQLN1) as essential oxidative stress-related genes with predictive value for the development of RIF ( Lin and Lin, 2022 ).…”